Alexis Dahl, in Hollywood, FL - Student in an Organized Health Care Education/Training Program

Alexis Dahl, is a Student In An Organized Health Care Education/training Program based in Hollywood, Florida. Alexis Dahl is licensed to practice in * (Not Available) (license number ) and her current practice location is 108 N 33rd Ct, Hollywood, Florida. She can be reached at her office (for appointments etc.) via phone at (305) 899-3230.

NPI number for Alexis Dahl is 1114627114 and her current mailing address is 108 N 33rd Ct, Hollywood, Florida. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1114627114.

Contact Information

	Alexis Dahl,
	108 N 33rd Ct, Hollywood, FL 33021-6912
	(305) 899-3230
	Not Available

Provider's Profile

Full Name	Alexis Dahl
Gender	Female
Speciality	Student In An Organized Health Care Education/training Program
Location	108 N 33rd Ct, Hollywood, Florida
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1114627114
Provider Enumeration Date: 03/08/2023
Last Update Date: 03/08/2023

Medical Identifiers

Medical identifiers for Alexis Dahl such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1114627114	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
163W00000X	Registered Nurse	9536461 (Florida)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alexis Dahl is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Alexis Dahl, 108 N 33rd Ct, Hollywood, FL 33021-6912 Ph: (305) 899-3230	Alexis Dahl, 108 N 33rd Ct, Hollywood, FL 33021-6912 Ph: (305) 899-3230

News Archive

Researchers study the effects of cocaine on patients diagnosed with schizophrenia

Alejandro Fuertes-Saiz, fourth-year Psychiatry intern at the Hospital Provincial de Castellón and doctoral candidate at the CEU Cardenal Herrera (CEU UCH) University of Valencia, along with his thesis directors, Gonzalo Haro and Ana Benito, have just published in journal Brain Science the final results of three year-long research where they have studied the effects of cocaine on patients diagnosed with schizophrenia or antisocial personality disorder.

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.

Satellite Healthcare, NKF partner to sponsor free Community Kidney Disease Symposium

Satellite Healthcare, one of the nation's first and leading not-for-profit providers of kidney dialysis services and a major sponsor of kidney research, is proud to announce that it has partnered with the National Kidney Foundation to sponsor NKF's free Community Kidney Disease Symposium this Saturday, November 16th in Stockton, California.

Tobacco use persists after liver transplant for alcoholic liver disease

Alcohol and tobacco often go hand-in-hand. Studies have shown that approximately 90 percent of problem drinkers also smoke or chew tobacco. But tobacco use is not adequately addressed when patients undergo liver transplantation due to alcoholic liver disease, say authors of a new report.

E. coli asparaginase linked to relapses in ALL patients with special form of ATF5 gene

One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when treated with E. coli asparaginase, a key chemotherapy drug for this type of leukemia.

Alexis Dahl, - Student in an Organized Health Care Education/Training Program in Hollywood, FL